JPRN-UMIN000007487
Recruiting
Phase 4
Blood-Glucose reduction in Type 2 Diabetes Patients when using two different DPP-4, alogliptin or sitagliptin during 52-week administration - Blood-Glucose reduction using DPP-4 agents
Biomedis International Ltd Study Management0 sites300 target enrollmentMarch 20, 2012
ConditionsType 2 diabetes
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Type 2 diabetes
- Sponsor
- Biomedis International Ltd Study Management
- Enrollment
- 300
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Type 1 diabetes or secondary diabetes 2\. Patients with severe infecious disease, operation planned or just after done, and/or serious externalinjyury 3\. Other DPP\-4 agents users on the enrollement 4\. Insulin users 5\. Pregnant and possible pregnant, or Lactation 6\. AST or ALT 2\.5 times or more of normalvalue 7\. Serum creatinine2 mg/dL or more 8\. Patients with old myocardial infarction, angina pectoris and/or stroke 9\. Patients having history of hypersensitivity against study drugs 10\.Inappropriate reasons on the enrollment that the physicians/investigators are judged
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Double blind, randomised, comparative, multicentre, parallel-group study design to evaluate the effects of Pioglitazone on cardiovascular risk markers in type 2 diabetes mellitusACTRN12608000534381Takeda Italia Farmaceutici S.p.A.100
Completed
Not Applicable
EXERFLOW STUDY:The effects of aerobic and resistance exercise training on vascular endothelial function in people with type 2 diabetes mellitusType 2 diabetesVascular function (endothelial function)Metabolic and Endocrine - DiabetesCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemACTRN12609000799257Baker IDI Heart and Diabetes Institute45
Active, not recruiting
Not Applicable
Assessment of blood glucose profile in type 2 diabetic patients after a one-week treatment with gliclazide 60 mg MR using both the glycaemic Holter method and multiple blood glucose samples.A double-blind, randomized, parallel group, placebo-controlled, exploratory study.Type 2 diabetes mellitusMedDRA version: 9.1Level: LLTClassification code 10012601Term: Diabetes mellitusEUCTR2008-002647-16-GBInstitut de Recherches Internationales Servier
Completed
Not Applicable
Glucose administration to type 2 diabetics influences metabolism during operatioType 2 diabetics undergoing surgery of body surface under general anesthesiaJPRN-UMIN000010145Tokushima University Hospital30
Not yet recruiting
Not Applicable
A Comparison of Peri-Operative and Post Acute Coronary Syndrome Glycaemic Control in Insulin Requiring Patients with Type 2 Diabetes at St Vincent’s Hospital With and Without Real-Time Continuous Glucose Monitoring.Type 2 diabetes requiring insulinAcute coronary syndromesPost - operative patientsMetabolic and Endocrine - DiabetesCardiovascular - Coronary heart diseaseSurgery - Surgical techniquesACTRN12608000125325St Vincent's Hospital60